These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 26119091)

  • 1. Embryonal Fyn-associated substrate (EFS) and CASS4: The lesser-known CAS protein family members.
    Deneka A; Korobeynikov V; Golemis EA
    Gene; 2015 Oct; 570(1):25-35. PubMed ID: 26119091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CAS proteins in normal and pathological cell growth control.
    Tikhmyanova N; Little JL; Golemis EA
    Cell Mol Life Sci; 2010 Apr; 67(7):1025-48. PubMed ID: 19937461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel Cas family member, HEPL, regulates FAK and cell spreading.
    Singh MK; Dadke D; Nicolas E; Serebriiskii IG; Apostolou S; Canutescu A; Egleston BL; Golemis EA
    Mol Biol Cell; 2008 Apr; 19(4):1627-36. PubMed ID: 18256281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NEDD9 and BCAR1 negatively regulate E-cadherin membrane localization, and promote E-cadherin degradation.
    Tikhmyanova N; Golemis EA
    PLoS One; 2011; 6(7):e22102. PubMed ID: 21765937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CAS proteins in health and disease: an update.
    Nikonova AS; Gaponova AV; Kudinov AE; Golemis EA
    IUBMB Life; 2014 Jun; 66(6):387-95. PubMed ID: 24962474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preclinical and clinical studies of the NEDD9 scaffold protein in cancer and other diseases.
    Shagisultanova E; Gaponova AV; Gabbasov R; Nicolas E; Golemis EA
    Gene; 2015 Aug; 567(1):1-11. PubMed ID: 25967390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adaptors for disorders of the brain? The cancer signaling proteins NEDD9, CASS4, and PTK2B in Alzheimer's disease.
    Beck TN; Nicolas E; Kopp MC; Golemis EA
    Oncoscience; 2014; 1(7):486-503. PubMed ID: 25594051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tyrosine dephosphorylation, but not phosphorylation, of p130Cas is dependent on integrin alpha IIb beta 3-mediated aggregation in platelets: implication of p130Cas involvement in pathways unrelated to cytoskeletal reorganization.
    Ohmori T; Yatomi Y; Inoue K; Satoh K; Ozaki Y
    Biochemistry; 2000 May; 39(19):5797-807. PubMed ID: 10801330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrin signalling: a new Cas(t) of characters enters the stage.
    O'Neill GM; Fashena SJ; Golemis EA
    Trends Cell Biol; 2000 Mar; 10(3):111-9. PubMed ID: 10675905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular basis for HEF1/NEDD9/Cas-L action as a multifunctional co-ordinator of invasion, apoptosis and cell cycle.
    Singh M; Cowell L; Seo S; O'Neill G; Golemis E
    Cell Biochem Biophys; 2007; 48(1):54-72. PubMed ID: 17703068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cas proteins: dodgy scaffolding in breast cancer.
    Tornillo G; Defilippi P; Cabodi S
    Breast Cancer Res; 2014; 16(5):443. PubMed ID: 25606587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural insights into the association between BCAR3 and Cas family members, an atypical complex implicated in anti-oestrogen resistance.
    Garron ML; Arsenieva D; Zhong J; Bloom AB; Lerner A; O'Neill GM; Arold ST
    J Mol Biol; 2009 Feb; 386(1):190-203. PubMed ID: 19103205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of CASS4 promotes invasion in non-small cell lung cancer by activating the AKT signaling pathway and inhibiting E-cadherin expression.
    Li A; Zhang W; Xia H; Miao Y; Zhou H; Zhang X; Dong Q; Li Q; Qiu X; Wang E
    Tumour Biol; 2016 Nov; 37(11):15157-15164. PubMed ID: 27677288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dcas supports cell polarization and cell-cell adhesion complexes in development.
    Tikhmyanova N; Tulin AV; Roegiers F; Golemis EA
    PLoS One; 2010 Aug; 5(8):e12369. PubMed ID: 20808771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A p130Cas tyrosine phosphorylated substrate domain decoy disrupts v-crk signaling.
    Kirsch K; Kensinger M; Hanafusa H; August A
    BMC Cell Biol; 2002 Jul; 3():18. PubMed ID: 12119061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Focal adhesion kinase regulates beta1 integrin-dependent T cell migration through an HEF1 effector pathway.
    van Seventer GA; Salmen HJ; Law SF; O'Neill GM; Mullen MM; Franz AM; Kanner SB; Golemis EA; van Seventer JM
    Eur J Immunol; 2001 May; 31(5):1417-27. PubMed ID: 11465098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HEF1 is a necessary and specific downstream effector of FAK that promotes the migration of glioblastoma cells.
    Natarajan M; Stewart JE; Golemis EA; Pugacheva EN; Alexandropoulos K; Cox BD; Wang W; Grammer JR; Gladson CL
    Oncogene; 2006 Mar; 25(12):1721-32. PubMed ID: 16288224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human enhancer of filamentation 1-induced colorectal cancer cell migration: Role of serine phosphorylation and interaction with the breast cancer anti-estrogen resistance 3 protein.
    Ibrahim R; Lemoine A; Bertoglio J; Raingeaud J
    Int J Biochem Cell Biol; 2015 Jul; 64():45-57. PubMed ID: 25817040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Cas family docking protein, HEF1, promotes the formation of neurite-like membrane extensions.
    Bargon SD; Gunning PW; O'Neill GM
    Biochim Biophys Acta; 2005 Dec; 1746(2):143-54. PubMed ID: 16344118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of CAS substrate domain tyrosine phosphorylation by FAK and Src.
    Ruest PJ; Shin NY; Polte TR; Zhang X; Hanks SK
    Mol Cell Biol; 2001 Nov; 21(22):7641-52. PubMed ID: 11604500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.